Adenovirus-catheter compatibility increases gene expression after delivery to porcine myocardium

Human Gene Therapy

Volumn 14, Issue 2, 2003, Pages 161-166

  Naimark, Wendy A ^a   Gorman III, Joseph H ^b   Palasis, Maria ^a   Parmacek, Michael S ^b   Wilensky, Robert L ^b   Lepore, John J ^b   Klugherz, Bruce D ^b   Wang, Zihua ^c   Guy, T Sloane ^b   Osman, Hashim ^b   Moainie, Sina L ^b   Gorman, Robert C ^b   Reed, Guy ^c  

^a BOSTON SCIENTIFIC CORPORATION   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; STAINLESS STEEL;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CATHETER; CONTROLLED STUDY; DNA VECTOR; ENDOCARDIUM; EPICARDIUM; GENE EXPRESSION; GENE THERAPY; HEART MUSCLE; INTERMETHOD COMPARISON; NONHUMAN; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ALLOYS; ANIMALS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HEART CATHETERIZATION; MYOCARDIUM; STAINLESS STEEL; SWINE;

ADENOVIRIDAE; ANIMALIA; SUIDAE;

EID: 0037258147     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403321070856     Document Type: Article

References (12)

1. BAO, J., NAIMARK, W., PALASIS, M., LAHAM, R.J., SIMONS, M., and POST, M.J. (2001). Intramyocardial delivery of FGF2 in combination with radio frequency transmyocardial revascularization. Cathet. Cardiovasc. Intervent. 53, 429-434.
2. BARR, E., CARROL, J., KALYNYCH, A.M., TRIPATHY, S.K., KOZARSKY, K., WILSON, J.M., and LEIDEN, J.M. (1994). Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1, 51-58.
3. GAL, D., WEIR, L., LECLERC, G., PICKERING, J.G., HOGAN, J., and ISNER, J. (1993). Direct myocardial transfection in two animal models. Lab. Invest. 68, 18-25.
4. LAHAM, R.J., REZAEE, M., POST, M., SELLKE, F.W., BRAECKMAN, R.A., HUNG, D., and SIMONS, M. (1999). Intracoronary and intravenous administration of basic fibroblast growth factor: Myocardial and tissue distribution. Drug Metab. Dispos. 27, 821-826.
5. LOGEART, D., HATEM, S.N., RUCKER-MARTIN, C., CHOSSAT, N., NEVO, N., HADDADA, H., HEIMBURGER, M., PERRI-CAUDET, M., and MERCADIER, J.-J. (2000). Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery. Hum. Gene Ther. 11, 1015-1022.
6. LOGEART, D., HATEM, S.N., HEIMBURGER, M., LE ROUX, A., MICHEL, J.-B., and MERCADIER, J.-J. (2001). How to optimize in vivo gene transfer to cardiac myocytes: Mechanical or pharmacological procedures? Hum. Gene Ther. 12, 1601-1610.
7. LOSORDO, D.W., VALE, P.R., SYMES, J.F., DUNNINGTON, C.H., ESAKOF, D.D., MAYSKY, M., ASHARE, A.B., LATHI, K., and ISNER, J.M. (1998). Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of ph VEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800-2804.
8. MARSHALL, D.J., PALASIS, M., LEPORE, J.J., and LIEDEN, J.M. (2000). Biocompatibility of cardiovascular gene delivery catheters with adenovirus vectors: An important determinant of the efficiency of cardiovascular gene transfer. Mol. Ther. 1, 423-429.
9. NAIMARK, W.A., WANG, Z., BALDWIN, S.P., KAJI, E., REED, G., and PALASIS, M. (2001). Building a compatible cardiovascular delivery catheter [abstract 740]. Mol. Ther. 3, S260.
10. ROSENGART, T.K., LEE, Y.L., PATEL, S.R., SANBORN, T.A., PARIKH, M., BERGMAN, G.W., HACHAMOVITCH, R., SZULC, M., KLIGFIELD, P.D., OKIN, P.M., HAHN, R.T., DEVEREUX, R.B., POST, M.R., HACKETT, N.R., FOSTER, T., GRASSO, T.M., LESSER, M.L., ISOM, O.W., and CRYSTAL, R.G., (1999). Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expression VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100, 468-474.
11. WILENSKY, R.L., MEHDI, K., SOWINSKI, K.M., BAEK, S.H., and MARCH, K.L. (1999). Increased intramural retention after local delivery of molecules with increased binding properties: Implications for regional delivery of pharmacologic agents. J. Cardiovasc. Pharmacol. Ther. 4, 103-112.
12. WRIGHT, M.J., WIGHTMAN, L.M., LATCHMAN, D.S., and MARBER, M.S. (2001). In vivo myocardial gene transfer: Optimization and evaluation of intracoronary gene delivery in vivo. Gene Ther. 8, 1833-1839.